Prekyba Morphosys AG - MOR CFD
Pridėti prie mėgstamų- Santrauka
- Istoriniai duomenys
- Įvykiai
- Pajamų ataskaita
- Balansas
- Pinigų srautai
- Nuosavybė
Skirtumas | 0.09 | ||||||||
Ilgos pozicijos nakties mokestis
Long position overnight fee
Eiti į platformą | -0.024161% | ||||||||
Trumpos pozicijos nakties mokestis
Short position overnight fee
Eiti į platformą | -0.020283% | ||||||||
Nakties mokesčio laikas | 22:00 (UTC) | ||||||||
Mažiausias parduodamas kiekis | 1 | ||||||||
Valiuta | EUR | ||||||||
Marža | 20% | ||||||||
Akcijų birža | Germany | ||||||||
Prekybos mokesčiai | 0% |
*Information provided by Capital.com
MorphoSys AG ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Ankstesnis uždarymas* | 19.23 |
Atviras* | 19 |
1 metų pokytis* | -31.56% |
Dienos intervalas* | 18.5 - 19 |
52 savaičių intervalas | 11.81-28.31 |
Vidutinė apimtis (10 dienų) | 108.88K |
Vidutinė apimtis (3 mėn.) | 7.20M |
Rinkos kapitalizacija | 650.41M |
P/E santykis | -100.00K |
Neišpirktos akcijos | 34.16M |
Pajamos | 249.61M |
EPS | -25.23 |
Dividendai (pajamingumas %) | N/A |
Beta | 0.73 |
Kito pelno data | Mar 15, 2023 |
Visus duomenis pateikė Refinitiv, išskyrus žvaigždute pažymėtus duomenis, kurie yra Capital.com pateikti *duomenys
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Uždarymas | Change | Change (%) | Atidarymas | High | Low |
---|---|---|---|---|---|---|
Feb 3, 2023 | 18.87 | -0.42 | -2.18% | 19.29 | 19.29 | 18.26 |
Feb 2, 2023 | 19.23 | 0.56 | 3.00% | 18.67 | 19.71 | 18.53 |
Feb 1, 2023 | 18.43 | 0.26 | 1.43% | 18.17 | 18.73 | 18.14 |
Jan 31, 2023 | 17.96 | 0.25 | 1.41% | 17.71 | 18.27 | 17.33 |
Jan 30, 2023 | 17.96 | 0.09 | 0.50% | 17.87 | 18.22 | 17.75 |
Jan 27, 2023 | 18.06 | 0.18 | 1.01% | 17.88 | 18.27 | 17.83 |
Jan 26, 2023 | 17.96 | 0.14 | 0.79% | 17.82 | 18.18 | 17.70 |
Jan 25, 2023 | 17.73 | 0.67 | 3.93% | 17.06 | 17.79 | 16.87 |
Jan 24, 2023 | 17.00 | -0.45 | -2.58% | 17.45 | 17.69 | 16.88 |
Jan 23, 2023 | 17.47 | 0.23 | 1.33% | 17.24 | 17.73 | 16.87 |
Jan 20, 2023 | 16.94 | 0.70 | 4.31% | 16.24 | 17.23 | 16.05 |
Jan 19, 2023 | 16.30 | -0.58 | -3.44% | 16.88 | 17.11 | 15.33 |
Jan 18, 2023 | 17.04 | 0.19 | 1.13% | 16.85 | 17.27 | 16.57 |
Jan 17, 2023 | 16.97 | 0.69 | 4.24% | 16.28 | 17.01 | 16.13 |
Jan 16, 2023 | 16.47 | -0.07 | -0.42% | 16.54 | 16.82 | 16.17 |
Jan 13, 2023 | 16.42 | 1.14 | 7.46% | 15.28 | 16.80 | 15.14 |
Jan 12, 2023 | 15.12 | -0.38 | -2.45% | 15.50 | 15.68 | 14.89 |
Jan 11, 2023 | 15.06 | 0.14 | 0.94% | 14.92 | 15.13 | 14.45 |
Jan 10, 2023 | 14.63 | 0.38 | 2.67% | 14.25 | 14.94 | 14.14 |
Jan 9, 2023 | 14.36 | 0.46 | 3.31% | 13.90 | 14.47 | 13.82 |
Morphosys AG Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Metinis
- Kas ketvirtį
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Visos pajamos | 49.7435 | 66.7908 | 76.4425 | 71.7553 | 327.698 | 179.612 |
Pajamos | 49.7435 | 66.7908 | 76.4425 | 71.7553 | 327.698 | 179.612 |
Pajamų sąnaudos, iš viso | 109.685 | 134.398 | 136.584 | 178.803 | 301.039 | 685.818 |
Pardavimas / Bendrosios / administravimo išlaidos, iš viso | 12.7561 | 15.7687 | 26.2302 | 55.7672 | 152.193 | 188.958 |
Tyrimai ir plėtra | 82.1921 | 103.315 | 83.988 | 103.861 | 120.489 | 219.072 |
Depreciation / Amortization | 3.764 | 4.03 | 3.75 | 3.458 | 7.255 | 7.557 |
Palūkanų sąnaudos (pajamos) - grynoji veikla | 0.208 | 0.359 | -0.22 | 0.18 | -18.237 | -13.584 |
Neįprastos išlaidos (pajamos) | 10.141 | 9.864 | 20.224 | 9.462 | 6.795 | 231.949 |
Other Operating Expenses, Total | 0.62335 | 1.06219 | 0.81471 | 2.67494 | 13.4374 | 19.6719 |
Veiklos pajamos | -59.941 | -67.6077 | -60.1411 | -107.048 | 26.6592 | -506.207 |
Palūkanų pajamos (išlaidos), grynosios ne veiklos pajamos | 0.132 | -0.768 | -0.237 | 1.354 | -35.614 | -81.632 |
Kita, pajamos | -0.05516 | -0.41446 | -0.0987 | -0.8269 | 31.4468 | -3.21234 |
Grynosios pajamos prieš mokesčius | -59.8642 | -68.7901 | -60.4768 | -106.52 | 22.492 | -591.051 |
Grynosios pajamos po mokesčių | -60.3828 | -69.8265 | -56.1721 | -103.014 | 97.8906 | -514.46 |
Grynosios pajamos prieš papildomas. Prekės | -60.3828 | -69.8265 | -56.1721 | -103.014 | 97.8906 | -514.46 |
Grynosios pajamos | -60.3828 | -69.8265 | -56.1721 | -103.014 | 97.8906 | -514.46 |
Pajamos, kurias galima gauti bendrai, išskyrus papildomas pajamas. Prekės | -60.3828 | -69.8265 | -56.1721 | -103.014 | 97.8906 | -514.46 |
Pajamos, kurias galima gauti bendrai, įskaitant papildomas pajamas. Prekės | -60.3828 | -69.8265 | -56.1721 | -103.014 | 97.8906 | -514.46 |
Skiedimo koregavimas | 0 | |||||
Skiedžiamas grynasis pelnas | -60.3828 | -69.8265 | -56.1721 | -103.014 | 97.8906 | -514.46 |
Skiedžiamas svertinis vidutinis akcijų skaičius | 26.4434 | 28.9476 | 31.3389 | 31.6112 | 33.1679 | 33.4011 |
Skiedžiamas pelnas už akcijas, neįskaitant ypatingų prekių | -2.28347 | -2.41217 | -1.79241 | -3.25879 | 2.95137 | -15.4025 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | 0 | 0 |
Skiedžiamas normalizuotas pelnas, gautas iš pelno | -2.0342 | -2.19068 | -1.20385 | -3.04945 | 3.20838 | -10.8879 |
Bendros pajamos, iš viso | 1.79663 | 3.4002 | 19.1071 | 32.1947 | ||
Pajamos | 74.6459 | 68.3551 | 308.591 | 147.417 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Visos pajamos | 47.1896 | 38.234 | 41.2448 | 52.9435 | 41.4665 |
Pajamos | 47.1896 | 38.234 | 41.2448 | 52.9435 | 41.4665 |
Bendros pajamos, iš viso | 5.04798 | 10.1363 | 7.48222 | 9.52819 | 7.89249 |
Pajamos | 42.1416 | 28.0977 | 33.7625 | 43.4153 | 33.574 |
Pajamų sąnaudos, iš viso | 76.4968 | 109.175 | 122.582 | 376.565 | 111.856 |
Pardavimas / Bendrosios / administravimo išlaidos, iš viso | 38.4237 | 40.1544 | 51.347 | 50.7098 | 36.4825 |
Tyrimai ir plėtra | 32.3171 | 40.5068 | 62.6749 | 87.0124 | 65.048 |
Palūkanų sąnaudos (pajamos) - grynoji veikla | -1.1 | 1.6 | -1.7 | -3.24 | |
Neįprastos išlaidos (pajamos) | -0.089 | 18.604 | 0.135 | 230.949 | 0.089 |
Other Operating Expenses, Total | 1.89697 | -1.8263 | 0.94256 | 1.60571 | 2.34434 |
Veiklos pajamos | -29.3072 | -70.9412 | -81.3369 | -323.621 | -70.3899 |
Palūkanų pajamos (išlaidos), grynosios ne veiklos pajamos | 7.1 | -7.7 | 4.2 | -95.782 | 3.4 |
Kita, pajamos | -33.8928 | 113.038 | -76.8684 | 4.06089 | -55.6612 |
Grynosios pajamos prieš mokesčius | -56.0999 | 34.3967 | -154.005 | -415.342 | -122.651 |
Grynosios pajamos po mokesčių | -41.6082 | 20.8942 | -112.772 | -380.974 | -122.651 |
Grynosios pajamos prieš papildomas. Prekės | -41.6082 | 20.8942 | -112.772 | -380.974 | -122.651 |
Grynosios pajamos | -41.6082 | 20.8942 | -112.772 | -380.974 | -122.651 |
Pajamos, kurias galima gauti bendrai, išskyrus papildomas pajamas. Prekės | -41.6082 | 20.8942 | -112.772 | -380.974 | -122.651 |
Pajamos, kurias galima gauti bendrai, įskaitant papildomas pajamas. Prekės | -41.6082 | 20.8942 | -112.772 | -380.974 | -122.651 |
Skiedžiamas grynasis pelnas | -41.6082 | 20.8942 | -112.772 | -380.974 | -122.651 |
Skiedžiamas svertinis vidutinis akcijų skaičius | 32.7586 | 35.3712 | 34.1332 | 34.1487 | 34.1488 |
Skiedžiamas pelnas už akcijas, neįskaitant ypatingų prekių | -1.27015 | 0.59071 | -3.30388 | -11.1563 | -3.59167 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | 0 |
Skiedžiamas normalizuotas pelnas, gautas iš pelno | -1.27191 | 1.20559 | -3.30892 | -6.76036 | -3.58906 |
Depreciation / Amortization | 1.7 |
- Metinis
- Kas ketvirtį
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Trumpalaikis turtas iš viso | 308.056 | 340.681 | 388.905 | 303.693 | 1206.82 | 1132.97 |
Pinigai ir trumpalaikės investicijos | 145.074 | 164.26 | 358.964 | 272.504 | 1090.32 | 993.664 |
Cash | 73.929 | 76.589 | 45.4598 | 44.314 | 109.795 | 123.248 |
Pinigai ir ekvivalentai | 1.25166 | 1.13313 | ||||
Trumpalaikės investicijos | 69.8938 | 86.5382 | 313.504 | 228.19 | 980.522 | 870.416 |
Gautinos sumos, iš viso, grynąja verte | 149.682 | 163.833 | 20.7414 | 20.3408 | 89.8356 | 85.79 |
Accounts Receivable - Trade, Net | 12.5967 | 11.2343 | 17.7329 | 15.0817 | 83.3543 | 75.911 |
Total Inventory | 0.31037 | 0.30075 | 0.24516 | 0.28821 | 9.96266 | 20.7552 |
Prepaid Expenses | 3.5 | 2.1 | 3.6 | 5.8 | 6.698 | 16.815 |
Other Current Assets, Total | 9.48947 | 10.1868 | 5.35488 | 4.75963 | 10.0035 | 15.9454 |
Total Assets | 463.6 | 415.398 | 538.764 | 496.439 | 1659.51 | 2556.25 |
Property/Plant/Equipment, Total - Net | 4.18911 | 3.52635 | 3.53071 | 47.8131 | 50.7415 | 49.5921 |
Property/Plant/Equipment, Total - Gross | 19.047 | 19.836 | 18.597 | 63.9362 | 68.4008 | 69.8613 |
Accumulated Depreciation, Total | -14.858 | -16.31 | -15.066 | -16.123 | -17.659 | -20.269 |
Goodwill, Net | 7.3648 | 7.3648 | 3.67623 | 3.67623 | 1.61923 | 335.574 |
Intangibles, Net | 60.5745 | 60.4821 | 43.6888 | 41.1221 | 69.3752 | 838.322 |
Note Receivable - Long Term | 79.5212 | 0 | ||||
Other Long Term Assets, Total | 3.89409 | 3.34429 | 2.98172 | 1.13603 | 134.373 | 199.796 |
Total Current Liabilities | 38.3019 | 47.701 | 45.9233 | 61.5579 | 200.459 | 284.538 |
Accounts Payable | 8.636 | 4.818 | 7.399 | 11.012 | 47.818 | 73.787 |
Accrued Expenses | 22.838 | 36.408 | 36.53 | 44.971 | 79.2 | 113.055 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 6.82795 | 6.47504 | 1.99429 | 3.04744 | 69.9627 | 94.0353 |
Total Liabilities | 48.1399 | 56.7272 | 50.3911 | 101.738 | 1038.19 | 2311.38 |
Total Long Term Debt | 0.21829 | 0.08779 | 0.07152 | 40.0416 | 314.724 | 322.13 |
Long Term Debt | 0.21829 | 0.08779 | 0.07152 | 0 | 272.76 | 282.785 |
Deferred Income Tax | 7.42184 | 7.81126 | 3.50723 | 0 | 5.05747 | 22.0654 |
Other Liabilities, Total | 2.19788 | 1.12709 | 0.88908 | 0.13809 | 517.951 | 1682.64 |
Total Equity | 415.46 | 358.671 | 488.373 | 394.702 | 621.322 | 244.876 |
Common Stock | 29.1598 | 29.4208 | 31.8396 | 31.958 | 32.89 | 34.2319 |
Additional Paid-In Capital | 428.361 | 438.558 | 619.908 | 628.177 | 748.979 | 833.321 |
Retained Earnings (Accumulated Deficit) | -27.5487 | -97.3751 | -152.766 | -255.78 | -157.889 | -672.349 |
Treasury Stock - Common | -14.6482 | -11.827 | -10.3988 | -8.35725 | -4.86874 | -3.08505 |
Unrealized Gain (Loss) | 0.1361 | -0.10548 | 0 | |||
Total Liabilities & Shareholders’ Equity | 463.6 | 415.398 | 538.764 | 496.439 | 1659.51 | 2556.25 |
Total Common Shares Outstanding | 28.7638 | 29.1011 | 31.5585 | 31.7322 | 32.7586 | 34.1488 |
Long Term Investments | 95.9811 | 98.999 | 196.588 | 0 | ||
Other Equity, Total | -0.21089 | -1.29572 | 2.21142 | 52.7576 | ||
Current Port. of LT Debt/Capital Leases | 2.52742 | 3.47855 | 3.66106 | |||
Capital Lease Obligations | 40.0416 | 41.9638 | 39.3458 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Trumpalaikis turtas iš viso | 1257.38 | 1255.91 | 1294.76 | 1132.97 | 1013.44 |
Pinigai ir trumpalaikės investicijos | 1122.26 | 1095.34 | 1155.19 | 993.664 | 855.47 |
Cash | 109.586 | 297.335 | 249.767 | 123.248 | 108.873 |
Trumpalaikės investicijos | 1012.67 | 798.01 | 905.426 | 870.416 | 746.597 |
Gautinos sumos, iš viso, grynąja verte | 104.173 | 108.192 | 82.0685 | 79.227 | 80.0492 |
Accounts Receivable - Trade, Net | 101.298 | 97.1665 | 77.044 | 75.911 | 74.0944 |
Total Inventory | 13.4 | 14.5171 | 13.2692 | 20.7552 | 20.89 |
Prepaid Expenses | 17.5465 | 37.8531 | 44.2278 | 39.3234 | 57.0263 |
Total Assets | 1649.91 | 1577.41 | 2883.94 | 2556.25 | 2457.36 |
Property/Plant/Equipment, Total - Net | 49.9224 | 49.4239 | 51.9162 | 49.5921 | 48.6483 |
Goodwill, Net | 1.61923 | 1.61923 | 570.959 | 335.574 | 342.343 |
Intangibles, Net | 69.0447 | 79.0253 | 787.906 | 838.322 | 853.209 |
Long Term Investments | 125.713 | 55.3782 | 0 | 0 | |
Other Long Term Assets, Total | 146.23 | 136.061 | 178.404 | 199.796 | 199.721 |
Total Current Liabilities | 202.263 | 204.554 | 259.123 | 284.538 | 238.959 |
Payable/Accrued | 124.297 | 134.663 | 168.399 | 188.077 | 145.55 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 4.02894 | 3.68179 | 4.09169 | 3.66106 | 5.31028 |
Other Current Liabilities, Total | 73.9369 | 66.2085 | 86.6328 | 92.8001 | 88.0983 |
Total Liabilities | 1070.25 | 976.007 | 2286.69 | 2311.38 | 2315.62 |
Total Long Term Debt | 316.63 | 318.27 | 320.184 | 322.13 | 322.835 |
Long Term Debt | 275.193 | 277.677 | 280.218 | 282.785 | 284.218 |
Capital Lease Obligations | 41.4369 | 40.5935 | 39.9657 | 39.3458 | 38.6175 |
Deferred Income Tax | 2.32821 | 5.05747 | 23.8584 | 22.0654 | 22.5267 |
Other Liabilities, Total | 549.032 | 448.126 | 1683.53 | 1682.64 | 1731.3 |
Total Equity | 579.653 | 601.407 | 597.25 | 244.876 | 141.739 |
Common Stock | 32.89 | 32.8925 | 34.2319 | 34.2319 | 34.2319 |
Additional Paid-In Capital | 749.846 | 749.284 | 832.584 | 833.321 | 833.376 |
Retained Earnings (Accumulated Deficit) | -199.497 | -178.603 | -291.375 | -672.349 | -795 |
Treasury Stock - Common | -4.86874 | -3.78304 | -3.37201 | -3.08505 | -3.08505 |
Other Equity, Total | 1.2836 | 1.61683 | 25.1808 | 52.7576 | 72.2164 |
Total Liabilities & Shareholders’ Equity | 1649.91 | 1577.41 | 2883.94 | 2556.25 | 2457.36 |
Total Common Shares Outstanding | 32.7586 | 32.7905 | 34.141 | 34.1488 | 34.1488 |
- Metinis
- Kas ketvirtį
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Grynosios pajamos / pradinė eilutė | -60.3828 | -69.8265 | -56.1721 | -103.014 | 97.8906 | -514.46 |
Pagrindinės veiklos pinigai | -46.6157 | -38.4459 | -32.7813 | -81.0702 | 34.5197 | -481.445 |
Pagrindinės veiklos pinigai | 3.76381 | 4.02895 | 3.75026 | 6.24516 | 8.32956 | 10.091 |
Nepiniginės prekės | -4.4191 | -3.29514 | 24.182 | -2.07177 | -83.4769 | 200.528 |
Cash Taxes Paid | 0.54038 | 1.86198 | 0.03384 | 0.06256 | 0.30397 | 64.6096 |
Sumokėtos palūkanos grynaisiais pinigais | 0.00182 | 0 | 0.13427 | 1.01132 | 1.43149 | 4.74485 |
Apyvartinio kapitalo pokyčiai | 14.4224 | 30.6468 | -4.54142 | 17.7704 | 11.7764 | -177.604 |
Investicinės veiklos pinigai | -80.786 | 32.9325 | -177.751 | 79.4841 | -879.623 | -831.01 |
Kapitalo išlaidos | -2.91349 | -13.1489 | -2.46532 | -3.66564 | -49.3365 | -26.1562 |
Kiti investiciniai pinigų srautų iš prekių, iš viso | -77.8726 | 46.0813 | -175.285 | 83.1497 | -830.286 | -804.854 |
Finansinės veiklos pinigai | 110.403 | 8.17382 | 179.462 | 0.35324 | 907.186 | 1322.92 |
Finansavimo pinigų srautų prekės | -2.78047 | -0.01553 | -15.1726 | -1.01132 | 508.655 | 1241.08 |
Akcijų išleidimas (išpirkimas), grynasis | 113.19 | 0 | 193.614 | 0 | 80.5985 | 84.73 |
Skolos išleidimas (padengimas), grynasis | -0.00671 | 8.18935 | 1.02085 | 1.36456 | 317.933 | -2.88511 |
Užsienio valiutos keitimo įtaka | 0 | -0.05946 | 0.08712 | 3.39766 | 2.98531 | |
Grynasis pinigų pokytis | -16.999 | 2.66047 | -31.1293 | -1.14579 | 65.4806 | 13.4536 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -41.6082 | -20.714 | -133.486 | -514.46 | -122.651 |
Cash From Operating Activities | -42.2207 | -131.585 | -323.96 | -481.445 | -143.812 |
Cash From Operating Activities | 2.31626 | 4.65405 | 7.3535 | 10.091 | 2.57174 |
Non-Cash Items | 16.223 | -79.0437 | -68.6942 | 200.528 | 36.1088 |
Cash Taxes Paid | 0.07992 | 0.08336 | 1.31085 | 64.6096 | 0.07782 |
Cash Interest Paid | 0.53635 | 2.21944 | 2.91855 | 4.74485 | 0.42117 |
Changes in Working Capital | -19.1517 | -36.4816 | -129.134 | -177.604 | -59.8415 |
Cash From Investing Activities | 33.1924 | 292.728 | -850.081 | -831.01 | 115.187 |
Capital Expenditures | -0.82796 | -12.4208 | -17.0882 | -26.1562 | -1.1706 |
Other Investing Cash Flow Items, Total | 34.0204 | 305.149 | -832.993 | -804.854 | 116.358 |
Cash From Financing Activities | 11.0258 | 27.857 | 1317 | 1322.92 | 13.7736 |
Financing Cash Flow Items | 11.8149 | 29.2795 | 1234.36 | 1241.08 | 14.5762 |
Issuance (Retirement) of Stock, Net | 0 | 0 | 84.7314 | 84.73 | |
Issuance (Retirement) of Debt, Net | -0.78905 | -1.42251 | -2.09185 | -2.88511 | -0.80261 |
Foreign Exchange Effects | -2.20631 | -1.45931 | -2.98555 | 2.98531 | 0.47603 |
Net Change in Cash | -0.20874 | 187.54 | 139.973 | 13.4536 | -14.3749 |
Investuotojo pavadinimas | Investuotojo tipas | Apyvartoje esantis procentas | Turimos akcijos | Turimų akcijų pokytis | Turėjimo data | Apyvartos vertinimas |
---|---|---|---|---|---|---|
JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 5.743 | 1965924 | 661108 | 2023-01-12 | LOW |
Armistice Capital LLC | Hedge Fund | 5.1648 | 1768000 | 732000 | 2023-01-10 | HIGH |
Goldman Sachs Asset Management, L.P. | Investment Advisor | 4.7869 | 1638637 | -39276 | 2023-01-18 | LOW |
T. Rowe Price International Ltd | Investment Advisor/Hedge Fund | 3.942 | 1349436 | -250322 | 2022-02-16 | MED |
RP Management, LLC | Private Equity | 3.9073 | 1337552 | 1337552 | 2021-07-29 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 3.6317 | 1243209 | 376568 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 3.2165 | 1101057 | -84879 | 2022-10-06 | LOW |
Adage Capital Management, L.P. | Hedge Fund | 3.2134 | 1100000 | 1100000 | 2022-12-02 | LOW |
Artisan Partners Limited Partnership | Investment Advisor | 2.9531 | 1010913 | 10045 | 2021-09-20 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.819 | 965001 | 11213 | 2022-12-31 | LOW |
Baillie Gifford & Co. | Investment Advisor | 2.4401 | 835292 | -1213122 | 2022-12-16 | LOW |
Morgan Stanley | Corporation | 1.5309 | 524062 | 524062 | 2022-11-21 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 1.3857 | 474360 | 0 | 2022-12-31 | LOW |
Bank of America Corp | Corporation | 1.2942 | 443038 | 128097 | 2022-12-22 | MED |
AMG Fondsverwaltung AG | Investment Advisor | 1.2112 | 414617 | 67321 | 2022-04-30 | LOW |
Eleva Capital SAS | Investment Advisor | 1.1824 | 404760 | 404760 | 2022-10-31 | HIGH |
Lupus alpha Asset Management AG | Investment Advisor/Hedge Fund | 1.1072 | 379000 | -52000 | 2022-10-31 | MED |
Mirova | Investment Advisor | 1.0159 | 347778 | -945 | 2022-11-30 | LOW |
Candriam Luxembourg S.A. | Investment Advisor | 0.9603 | 328727 | 0 | 2022-12-31 | HIGH |
Macquarie Investment Management | Investment Advisor | 0.8764 | 300000 | 0 | 2022-12-31 | LOW |
Kodėl Capital.com? Mūsų skaičiai kalba už save.
Capital.com GroupPrekeiviai
Aktyvūs klientai kas mėnesį
Mėnesio investicijų apimtis
Atsiimama kas mėnesį
Prekybos skaičiuoklė
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Morphosys Company profile
Apie Morphosys AG
"MorphoSys AG" kuria ir prekiauja antikūnais, skirtais gydymui. Bendrovė kuria vaistus naudodama savo tyrimus ir plėtrą, taip pat bendradarbiaudama su farmacijos ir biotechnologijų partneriais. Bendrovės veiklos segmentai yra "Proprietary Development" ir "Partnered Discovery". Nuosavybinio kūrimo segmente ji kuria terapinius antikūnus ir peptidus uždegiminių ligų ir onkologijos srityse. "Partnered Discovery" segmente bendrovė taiko technologijas terapinių antikūnų, kaip vaistų kandidatų, tyrimams, kūrimui ir optimizavimui. Bendrovė kuria naujus gydymo būdus sunkiomis ligomis sergantiems pacientams. Bendrovės technologijos apima "HuCAL" - žmogaus antikūnų rinkinį ir jų optimizavimo sistemą; "Ylanthia" - antikūnų biblioteką Fab formatu ir "Slonomics" - automatizuotą genų sintezės ir modifikavimo technologiją, skirtą genų bibliotekų kūrimui kontroliuojamu procesu.
Industry: | Biotechnology & Medical Research (NEC) |
Semmelweisstr. 7
PLANEGG
BAYERN 82152
DE
Pajamų ataskaita
- Annual
- Quarterly
Žmonės taip pat žiūri
Vis dar ieškote brokerio kuriuo galėtumėte pasitikėti?
Prisijunkite prie 485 000+ prekeivių visame pasaulyje, kurie pasirinko prekybą su Capital.com